TY - JOUR
T1 - Analysis of action potentials in the canine ventricular septum
T2 - No phenotypic expression of M cells
AU - Morita, Shiho T.
AU - Zipes, Douglas P.
AU - Morita, Hiroshi
AU - Wu, Jiashin
N1 - Funding Information:
This research was supported by award 0455517Z from American Heart Association Midwest Affiliation and by the Herman C. Krannert Fund, Indianapolis.
PY - 2007/4/1
Y1 - 2007/4/1
N2 - Objective: Transmural heterogeneity in the ventricular free wall, enhanced by the midmyocardial long action potential duration (APD) of M cells, plays an important role in the arrhythmogenesis of long QT syndrome. Although we observed dynamic expression of M cell phenotypes in the canine ventricular free wall, it is still unclear whether similar phenomena are present in the interventricular septum. This study evaluated transmural heterogeneity of APD in the septum. Methods: We isolated and perfused 22 canine septal preparations through the septal branch of the anterior descending coronary artery, and optically mapped 256 channels of action potentials on their cut-exposed transseptal surfaces before and after treatment with sotalol (IKr blocker), anemone toxin II (ATX-II, which slows the inactivation of INa), or drug-free state in 6, 9, and 22 preparations, respectively. The preparations were paced from the left ventricular endocardium at cycle lengths of 500, 1000, 2000, and 4000 ms. Results: We observed progressively lengthening of APD across the septum from the right ventricular to the left ventricular endocardium without a midmyocardial maximum under all conditions. All action potentials had minor phase-1 notches, resembling the endocardial action potential in the ventricular free wall. Increasing cycle lengths and concentrations of sotalol and ATX-II prolonged APD without midmyocardial preference and increased the transseptal dispersion of APDs. Conclusions: Canine interventricular septal action potentials are similar in shape to the endocardial action potentials in the ventricular free wall, with smooth transseptal transition in APD. We found no phenotypical expression of M cells in the canine interventricular septum.
AB - Objective: Transmural heterogeneity in the ventricular free wall, enhanced by the midmyocardial long action potential duration (APD) of M cells, plays an important role in the arrhythmogenesis of long QT syndrome. Although we observed dynamic expression of M cell phenotypes in the canine ventricular free wall, it is still unclear whether similar phenomena are present in the interventricular septum. This study evaluated transmural heterogeneity of APD in the septum. Methods: We isolated and perfused 22 canine septal preparations through the septal branch of the anterior descending coronary artery, and optically mapped 256 channels of action potentials on their cut-exposed transseptal surfaces before and after treatment with sotalol (IKr blocker), anemone toxin II (ATX-II, which slows the inactivation of INa), or drug-free state in 6, 9, and 22 preparations, respectively. The preparations were paced from the left ventricular endocardium at cycle lengths of 500, 1000, 2000, and 4000 ms. Results: We observed progressively lengthening of APD across the septum from the right ventricular to the left ventricular endocardium without a midmyocardial maximum under all conditions. All action potentials had minor phase-1 notches, resembling the endocardial action potential in the ventricular free wall. Increasing cycle lengths and concentrations of sotalol and ATX-II prolonged APD without midmyocardial preference and increased the transseptal dispersion of APDs. Conclusions: Canine interventricular septal action potentials are similar in shape to the endocardial action potentials in the ventricular free wall, with smooth transseptal transition in APD. We found no phenotypical expression of M cells in the canine interventricular septum.
KW - Arhythmia (mechanisms)
KW - Mapping
KW - QT-dispersion
KW - Repolarization
UR - http://www.scopus.com/inward/record.url?scp=33847690619&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847690619&partnerID=8YFLogxK
U2 - 10.1016/j.cardiores.2007.01.003
DO - 10.1016/j.cardiores.2007.01.003
M3 - Article
C2 - 17266946
AN - SCOPUS:33847690619
SN - 0008-6363
VL - 74
SP - 96
EP - 103
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 1
ER -